Trials / Completed
CompletedNCT03242759
Non-Interventional Study (NIS) Collecting Experiences For IPF in Taiwan
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 101 (actual)
- Sponsor
- Boehringer Ingelheim · Industry
- Sex
- All
- Age
- 20 Years
- Healthy volunteers
- Not accepted
Summary
This is a non-interventional, multi-center study to collect data from patients with idiopathic pulmonary fibrosis (IPF) in clinical practice in Taiwan. The study will be carried out at 10 medical centers, the expert centers where IPF patients are mainly managed in Taiwan.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | nintedanib | Drug |
| DRUG | pirfenidone | Drug |
Timeline
- Start date
- 2017-08-17
- Primary completion
- 2020-02-18
- Completion
- 2020-02-18
- First posted
- 2017-08-08
- Last updated
- 2021-04-13
- Results posted
- 2021-03-08
Locations
10 sites across 1 country: Taiwan
Source: ClinicalTrials.gov record NCT03242759. Inclusion in this directory is not an endorsement.